Anti-tumor drug supervision in China from 2010 to 2024: the evolution and prospect of drug review standards.
作者信息
Tang Ling, Song Yuanyuan, Zhang Hong, Hao Ruimin, Tong Xin, Ai Xing, Ma Jun, Yang Zhimin
机构信息
Office of Clinical Trial Management, Center for Drug Evaluation, National Medical Products Administration, Beijing, P. R. China.
Office of Clinical Evaluation 1, Center for Drug Evaluation, National Medical Products Administration, Beijing, P. R. China.
出版信息
Cancer Commun (Lond). 2025 Jan;45(1):63-67. doi: 10.1002/cac2.12630. Epub 2024 Nov 20.
Abstract
摘要
Zotero 插件